May 2 (Reuters) - HistoSonics, a medical technology
company backed by Johnson & Johnson ( JNJ ), is exploring a
potential sale after receiving multiple takeover approaches, the
Financial Times reported on Friday, citing people familiar with
the matter.
The company is seeking a valuation of more than $2.5
billion, the report said.